The ESC Textbook of Heart Failure

by Petar Seferovic, Andrew Coats, Gerasimos Filippatos, Johann Bauersachs, Giuseppe Rosano

Overview

The ESC Textbook of Heart Failure is the latest addition to the European Society of Cardiology (ESC) publications portfolio and is fully supported by the European Heart Failure Association.
The textbook brings together internationally renowned experts in the field of heart failure to present an up-to-date understanding of all aspects of this chronic condition that worsens with time. It is estimated that the worldwide population of patients suffering from heart failure is approximately 26 million. This clinically oriented work reflects contemporary European guidelines from the ESC and the European Heart Failure Association and summarizes the latest evidence from clinical trials.
Made up of eighteen different sections the textbook covers the epidemiology, etiology, prevention, pathophysiology, and clinical phenotypes of heart failure. The assessment and management of chronic, acute, and advance heart failure are all discussed in detail. As well as chapters dedicated to self-care and patient education, the multidisciplinary approach to heart failure management, and clinical trial design and interpretation. The future direction of the field is discussed throughout with separate chapters on digital health, big data, and telemedicine/remote monitoring in heart failure also included.
A must read for cardiovascular healthcare specialists in Europe and across the world it should also appeal to those in training, general physicians and those caring of the elderly, cardiothoracic surgeons, primary care doctors, and specialist nurses too.

Product Details

ISBN-13:	9780198891628
Publisher:	Oxford University Press
Publication date:	02/09/2024
Series:	The European Society of Cardiology Series
Pages:	1040
Product dimensions:	10.90(w) x 9.60(h) x 2.60(d)

Table of Contents

Section 1: Universal definition of heart failure1.1. Universal definition of heart failure, Andrew JS Coats, Biykem Bozkurt and Petar M. SeferovicSection 2: Epidemiology of heart failure2.1. Epidemiology of heart failure, Amy Groenewegen, Ivan Milinkovi?, Arno W Hoes, Arend Mosterd, Frans H RuttenSection 3: Etiology of heart failure3.1. Coronary artery disease, (Rocco Antonio Montone, Maurizio Volterrani, Jian Zhang and Filippo Crea3.2. Hypertension, Athanasios Manolis and Yuri Lopatin3.3. Valvular heart disease, Ana Pardo Sanz, Ivan Milinkovic and Josep Zamorano3.4.1. Genetic basis of cardiomyopathies, Thomas Thum, Stephane Heymans, and Johannes Backs3.4.2. Dilated and hypokinetic non-dilated cardiomyopathy, Petar M.Seferovic, Biykem Bozkurt, and Marija Polovina3.4.3. Hypertrophic cardiomyopathy, Perry Elliott, Michel Noutsias and Aris Anastasakis3.4.4. Restrictive cardiomyopathy, Claudio Rapezzi, Alberto Aimo, Ales Linhart, and Andre Keren3.4.5. Arrhythmogenic right ventricular cardiomyopathy, Cristina Basso, Hugh Calkins and Domenico Corrado3.4.6. Peripartum cardiomyopathy, Karen Sliwa and Johann Bauersachs3.4.7. Takotsubo cardiomyopathy, Jelena Templin-Ghadri, Michael Würdinger, Johann Bauersachs, and Christian Templin3.5. Myocarditis and pericarditis, Stephane Heymans, Arsen Risti?, Yehuda Adler, and Massimo Imazio3.6. Congenital heart disease, Werner Budts and Jolien Roos-Hesselink3.7. Endocrine and metabolic disorders, Martin Huelsmann, Jelena Seferovic and Francesco Cosentino3.8. Obesity, Lina Badimon, Stefan Anker and Stephan von Haehling3.9. Cancer and cancer therapy, Alexander Lyon, Dimitrios Farmakis, Daniela Cardinale and Teresa Lopez Fernandez3.10. Toxins (e.g. alcohol etc.) and infections, Antonello Gavazzi, Maria Nunes, and Fausto PintoSection 4: Prevention of heart failure4.1. Prevention of heart failure, Massimo Piepoli, Maria Benedetta Matrone, Paul Dendale, and Shelley ZierothSection 5: Pathophysiology of heart failure5.1. Molecular and cellular mechanisms, (Junjie Xiao, Thomas Thum, Gianluigi Condorelli and Johannes Backs5.2. Alterations in myocardial metabolism, Edoardo Bertero and Chistoph Maack5.3. Ventricular remodelling, Javier Diez Martinez and Hans-Peter Brunner La Rocca5.4. Neurohormonal activation, Antoni Bayes Gennis and Faiez Zannad5.5. Immune-mediated mechanisms, Urlich Hofmann, Stefan Frantz and Nikolaos Frangogiannis5.6. Inflammation, oxidative stress and endothelial dysfunction, Stephane Heymans5.7. Alterations in peripheral circulation and renal function, Alterations in peripheral circulation and renal function (5.8. Systemic adaptations in metabolism and nutritive status, (Stephan von Haehling and Wolfram DoehnerSection 6: Clinical phenotypes of chronic heart failure6.1. HFrEF, Thomas Luscher, Petar Seferovic, and Brian Halliday6.2. HFmrEF, Adrian Voors, Brenda Moura, Lars Lund and Carolyn Lam6.3. HFpEF, Rudolf De Boer, Burkert Pieske, and Barry Borlaug6.4. Right heart failure, Thomas Luscher, Thomas M. Gorter, Susanna Price, Michael Gatzoulis and Anneline Te RieleSection 7: Chronic heart failure: diagnostic and prognostic assessment7.1. Clinical assessment, Michel Komajda, Piotr Ponikowski, and Evgeny Shlyakhto7.2. Biomarkers in diagnostic and prognostic assessment, Rudolf de Boer, Antioni Bayes Genis and James Januzzi7.3. Echocardiography, Philippe Debonnaire, Victoria Delgado, Thor Edvardsen, Bogdan Popescu, and Jeroen Bax7.4. Nuclear medicine, Danilo Neglia and Alessia Gimelli7.5. Cardiac computed tomography, Stephan Achenbach and Amina Rakisheva7.6. Cardiac magnetic resonance, Anna Baritussio, Noor Sharrack, Sven Plein, and Chiara Bucciarelli-Bucci7.7. Cardiopulmonary exercise, Luca Moderato, Davide Lazzeroni, Stamatis Adamopoulos, Alain Cohen-Solal and Massimo Piepoli7.8. Cardiac catheterization, invasive imaging and haemodynamic assessment, Christian Hamm, Brigit Assmus and Veselin MitrovicSection 8: Chronic heart failure: pharmacological management8.1. Angiotensin converting enzyme inhibitors, Roberto Ferrari, Gabriele Guardigli, and Biykem Bozkurt8.2. Angiotensin I receptor blockers, Ileana L. Pina and Magdy Abdelhamid8.3. ARNI, Petar M. Seferovic, Michele Senni, Marija Polovina and Andrew JS Coats8.4. Beta-blockers, Daniela Tomasoni, Marianna Adamo, Hiroyuki Tsutsui, and Marco Metra8.5. Mineralocorticoid receptor agonists, Bertram Pitt, João Pedro Ferreira and Faiez Zannad8.6. Ivabradine, Michael Bohm and Michel Komajda8.7. Vasodilators, Eftihia Polyzogopoulou, Maria Nikolaou, John Parissis and Alexandre Mebazaa8.8. Digitalis glycosides, Udo Bavendiek and Johann Bauersachs8.9. Diuretics, Jeroen Dauw, Stephen Gottlieb and Wifried Mullens8.10. Inotropes and inodilators, Jan Biegus, Piotr Ponikowski, and Christoph Maack8.11. SGLT2 inhibitors, Petar M. Seferovic, Francesco Cosentino, Giuseppe Rosano and James Januzzi8.12. Ancillary pharmacological treatment options, Stefan Agewall, Isabelle van Gelder, and Irene Savelieva8.13. New and emerging therapies, Giuseppe Rosano, Gerasimos Filippatos, and Randall StarlingSection 9: Chronic heart failure: non-pharmacological management9.1. Implantable cardioverter defibrillator, Gianluigi Savarese, Cecilia Linde and Kenneth Dickstein9.2. Cardiac resynchronization therapy, Pieter Martens, Eva Goncalvesova, and Wilfried Mullens9.3. Cardiac surgery, Felix Schoenrat, Franz-Josef Neumann, Miguel Sousa Uva and Volkmar Falk9.4. Valve interventions, Stefan Orwat, Stefan Anker and Helmut Baumgartner9.5. Ancillary procedures, Andrew JS Coats, Piotr P Ponikowski, Maria-Rosa Costanzo and William T. Abraham9.6. Cardiac rehabilitation, Maurizio Volterrani, Alain Cohen-Solal, Stamatis Adamopulos, Dimitris Miliopoulos, Ferdinando Iellamo, and Massimo PiepoliSection 10: Acute heart failure10.1. Acute heart failure: diagnostic and prognostic assessment, Ovidiu Chioncel, Gerasimos Filippatos, Alexandre Mebazaa, Veli-Pekka Harjola, and Josep Masip10.2. Acute heart failure: management, Katerina Fountoulaki, John Parissis, Sean Collins, Mehmet Birhan Yilmaz, and Alexandre MebazaaSection 11: Advanced heart failure11.1. Advanced heart failure: assessment, Tuvia Ben Gal, Mariell Jessup, and Maria-Rosa Costanzo11.2. Advanced heart failure: management, Daniela Tomasoni, Marianna Adamo, and Marco Metra11.3. Mechanical circulatory support, Mandeep Mehra and Finn Gustafsson11.4. Heart transplantation, Davor Milicic, Mandeep Mehra, and Randall Starling11.5. Palliative care and end-of-life management, Tiny Jaarsma, Donna Fitzsimons, Lisa Hjelmfors, Loreena Hill, Ekaterini Lambrinou, and Anna StrömbergSection 12: Comorbidities and clinical conditions12.1. Chronic kidney disease: Clinical Aspects of Chronic Kidney Disease in Heart Failure, Pieter Martens and Hans-Peter Brunner-La Rocca12.2. Dyskalaemia, Javed Butler, Wilfried Mullens and Kevin Damman and João Pedro Ferreira12.3. Chronic lung disease, Josep Masip, Karina Portillo and Mattia Arrigo12.4. Ventilatory Abnormalities and Sleep Disordered Breathing, Piergiuseppe Agostoni, Elisabetta Salvioni, Maria Rosa Costanzo, and Andrew JS Coats12.5. Pulmonary hypertension, Irene M. Lang and Stephan Rosenkranz12.6. Cardiac rhythm disorders, Silvia Priori, Alessandro Trancuccio, Alessia Chiara Latini, Carlo Arnò, Deni Kukavica, and Andrea Mazzanti12.7. Management of atrial fibrillation in heart failure, Paulus Kirchhof, Andreas Metzner, Ruben Schleberger and Douglas Packer12.8. Diabetes, metabolic syndrome and endocrine disorders, Giuseppe Rosano, Javed Butler, Petar M. Seferovi?, Jelena Seferovic and Francesco Cosentino12.9. Systemic immune medicated diseases, Giacomo De Luca, Luca Moroni, Alessandro Tomelleri, R Marcolongo, Lorenzo Dagna, Alida LP Caforio, and Marco Matucci-Cerinic12.10. Liver and gut dysfunction, Yuri Lopatin and Gianluigi Savarese12.11. Anaemia and iron deficiency, Ewa Jankowska, Piotr Ponikowski, and Stefan Anker12.12. Depression and cognitive impairment, Wolfram Doehner, Cristiana Vitale, and Mehmet Birhan Yilmaz12.13. Cancer, Alexander Lyon, Dimitrios Farmakis, Rudolf de Boer, and Yuri Belenkov12.14. Pregnancy, Johann Bauersachs, Denise Hilfiker-Kleiner and Karen Sliwa12.15. Frailty, Ewa Jankowska, Cristiana Vitale and Dong-Ju ChoiSection 13: Self-care and patient education13.1. Self-care and patient education, Tiny Jaarsma, Loreena Hill, Ekaterini Lambrinou, Anna Stromberg, and Tina HansenSection 14: Multidisciplinary approach to heart failure management14.1. Multidisciplinary approach to heart failure management, Loreena Hill, Friedrich Koehler, Tiny Jaarsma, Marija Polovina, Katherine McCreary, and Andrew JS CoatsSection 15: Clinical trial design and interpretation15.1. Clinical trial design and interpretation, Gianluigi Savarese, Marija Polovina and Gerasimos FilippatosSection 16: Digital health in heart failure16.1. Digital health in heart failure, Arvind Singhal and Martin CowieSection 17: Big data in heart failure17.1. Big data in heart failure, Mamas Mamas and Dipak KotechaSection 18: Telemedicine and remote monitoring18.1. Telemedicine and remote monitoring, Tarek Bekfani, Friedrich Koehler and William T. Abraham

Editorial Reviews

"The textbook is of utmost quality and provides a massive tool to physicians at all levels. The quantity of information provided is exceptional, and the coverage of topics relating to heart failure is as precise as ever [...] The book outranks many of its related counterparts as it not only covers the theoretical aspects of the disease but also dives deep into the management strategies, diagnostic technologies, and latest advances in the disease." — Jonathan Rzonzew, Universidad San Francisco de Quito

From the Publisher

Reviewer: Jonathan Rzonzew, MD Candidate(Universidad San Francisco de Quito)
Description: This book is a consensus referenced guideline on heart failure from the European Society of Cardiology. The book brings together international experts in the cardiovascular field and presents an integral overview of heart failure in all its forms.
Purpose: The book is a comprehensive, up-to-date guideline on heart failure covering all aspects of the disease ranging from basic definition and etiology to detailed management and diagnostics. It provides a thorough description of the condition from a general standpoint initially, followed by a minute step-by-step multidisciplinary approach with strategic diagnostic techniques and precise management guidelines for a diverse array of patients. The objective of the book is to educate physicians on all aspects of an ever-expanding disease, providing understanding built from the basic aspects of disease manifestations to the most specific tools implemented on its control.
Audience: The primary audience of the book is physicians dealing with patients with heart failure, most importantly cardiovascular healthcare specialists but also including primary care doctors, general physicians, specialist nurses, cardiothoracic surgeons, and physicians in training.
Features: The book is divided into 18 sections including multiple chapters each. Section 1 starts off the book with the basic definition of heart failure. Section 2 covers epidemiology. Section 3 dives into the etiology of the disease covering ischemic causes, hypertension, and valvular disease, as well as a thorough review of cardiomyopathies responsible for heart failure as well as other related diseases and causes. Section 4 mentions preventive strategies. Section 5 provides an integral explanation of the pathophysiological mechanisms behind heart failure such as ventricular remodeling, inflammation and oxidative stress, systemic adaptations, and other mechanisms. Section 6 focuses on the clinical phenotypes of heart failure, covering variations in ejection fraction and its manifestations on clinical symptoms. Section 7 reviews chronic heart failure diagnostics and prognosis based on disease progression, with a detailed review of imaging studies fundamental in the diagnosis of the disease. Section 8 covers the pharmacological management strategies; everything from ACEi, ARNIs, MRA, SGLT2i, BB, and diuretics, among other pharmacological agents, including emerging approaches such as the novel omecamtiv mecarbil. Section 9 covers non-pharmacological approaches, namely intra-cardiac devices, and procedures. Sections 10 and 11 divide the onset of heart failure into acute and advanced respectively and mention concise strategies for the diagnosis and management of each. Section 13 provides an all-round coverage of associated comorbidities including pulmonary conditions, gastrointestinal comorbidities, electrolyte induced abnormalities, and other medical scenarios related to heart failure, including pregnancy. Sections 13 through 18 discuss the literary aspects of the disease, including self-care and patient education, multidisciplinary approaches to management, clinical trial designs and interpretations, digital health, big data, and telemedicine and remote monitoring.
Assessment: The textbook is of utmost quality and provides a massive tool to physicians at all levels. The quantity of information provided is exceptional, and the coverage of topics relating to heart failure is as precise as ever. The visual distribution of the text is appealing, and it is filled with easy to interpret tables, graphs, visual representations and images, flowcharts and algorithms that condense information into an easy-to-follow scheme for the reader. The references included are of high quality as well, although the focus is limited to the European community mainly. Nonetheless, being a global disease, its content contains worldwide utility. The book outranks many of its related counterparts as it not only covers the theoretical aspects of the disease but also dives deep into the management strategies, diagnostic technologies, and latest advances in the disease.

Doody's Review Service